Cargando…

Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited

Purpose. To correlate the radiological aspects of metastases, the response to chemotherapy, and patient outcome in disseminated childhood medulloblastoma. Patients and Methods. This population-based study concerned 117 newly diagnosed children with disseminated medulloblastoma treated at the Institu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dufour, Christelle, Beaugrand, Annick, Pizer, Barry, Micheli, Julie, Aubelle, Marie-Stephanie, Fourcade, Aurelie, Couanet, Dominique, Laplanche, Agnes, Kalifa, Chantal, Grill, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265270/ https://www.ncbi.nlm.nih.gov/pubmed/22312539 http://dx.doi.org/10.1155/2012/245385

Ejemplares similares

Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
por: Huybrechts, Sophie, et al.
Publicado: (2020)

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
por: Maritaz, Christophe, et al.
Publicado: (2018)

Long Time to Diagnosis of Medulloblastoma in Children Is Not Associated with Decreased Survival or with Worse Neurological Outcome
por: Brasme, Jean-Francois, et al.
Publicado: (2012)

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

MBCL-02. ROLE OF PREOPERATIVE CHEMOTHERAPY IN METASTATIC MEDULLOBLASTOMA: A COMPARATIVE STUDY IN 92 CHILDREN
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
por: Schwalbe, Edward C, et al.
Publicado: (2017)

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
por: Boland, I, et al.
Publicado: (1999)

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma
por: Lafay-Cousin, Lucie, et al.
Publicado: (2022)

Temozolomide in paediatric high-grade glioma: a key for combination therapy?
por: Verschuur, A C, et al.
Publicado: (2004)

Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021)

Endocrine complications in survivors of childhood medulloblastoma
por: Yuet-ling, Joanna Tung, et al.
Publicado: (2015)

Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature
por: Siegfried, Aurore, et al.
Publicado: (2016)

Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
por: Rickert, Daniel, et al.
Publicado: (2021)

Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications
por: von Hoff, Katja, et al.
Publicado: (2008)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Chemotherapy for unresectable and recurrent intramedullary glial tumours in children
por: Doireau, V, et al.
Publicado: (1999)

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
por: Richardson, Stacey, et al.
Publicado: (2021)

MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS
por: Kolodziejczak, Anna, et al.
Publicado: (2023)

Pathology, diagnostics, and classification of medulloblastoma
por: Orr, Brent A.
Publicado: (2020)

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics
por: Crosier, Stephen, et al.
Publicado: (2021)

Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey
por: Lobón, Maria Jesus, et al.
Publicado: (2016)

MBRS-44. TIME, PATTERN AND OUTCOME OF MEDULLOBLASTOMA RELAPSE ARE ASSOCIATED WITH TUMOUR BIOLOGY AT DIAGNOSIS AND UPFRONT THERAPY: A COHORT STUDY
por: Hill, Rebecca, et al.
Publicado: (2020)

Childhood medulloblastoma in Britain 1971-77: analysis of treatment and survival.
por: Stiller, C. A., et al.
Publicado: (1983)

A preliminary study on the mechanism of VASH2 in childhood medulloblastoma
por: Liu, Wen, et al.
Publicado: (2023)

Childhood Cutaneous Mastocytosis: Revisited
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study
por: Hill, Rebecca M, et al.
Publicado: (2020)

Relationships between Regional Radiation Doses and Cognitive Decline in Children Treated with Cranio-Spinal Irradiation for Posterior Fossa Tumors
por: Doger de Speville, Elodie, et al.
Publicado: (2017)

MBRS-60. THE ACTIONABLE GENOMIC LANDSCAPE OF RELAPSED MEDULLOBLASTOMA IS DEFINED BY MAINTENANCE AND ACQUISITION OF DRIVER EVENTS
por: Richardson, Stacey, et al.
Publicado: (2020)

Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Medulloblastoma: molecular pathways and histopathological classification
por: Borowska, Anna, et al.
Publicado: (2016)

Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells
por: von Bueren, André O, et al.
Publicado: (2007)

Thyroid dysfunction in patients with childhood-onset medulloblastoma or primitive neuroectodermal tumor
por: Jin, Seung Young, et al.
Publicado: (2018)

Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol
por: Kartal, İbrahim, et al.
Publicado: (2023)

MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA
por: Dufour, Christelle, et al.
Publicado: (2020)

p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma
por: Meley, D, et al.
Publicado: (2010)

Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy
por: Rakotonjanahary, Josué, et al.
Publicado: (2015)

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
por: Williamson, Daniel, et al.
Publicado: (2022)

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
por: Gilbertson, R. J., et al.
Publicado: (1995)

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2009)

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
por: van Vuurden, Dannis G., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rk5i03knp58mprjichhcao8jok